2008 U.S. Diabetes Drug Delivery - Patient Perspective

2008 U.S. Diabetes Drug Delivery - Patient Perspective

 

RELEASE DATE
31-May-2010
REGION
North America
Research Code: N7C0-01-00-00-00
SKU: HC02157-NA-CR_07749

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02157-NA-CR_07749

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This study encompasses feedback provided by U.S. diabetes patients on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current and future trends. Data was presented for the general objective point questions as well as analysis by disease subtype where applicable. Patient feedback about awareness, usage, and desired changes was obtained for Exubera and Byetta. For device driven delivery, autoinjector technology usage and willingness for adoption is assessed by patients, as well as other vital feedback on the role the device plays in the overall drug product. The corresponding physician deliverable is titled: 2008 U.S. Diabetes Drug Delivery - Physician Perspective (N7A6).

Table of Contents

Introduction

  • Title
  • Disclaimer
  • Certification
  • Table of Contents

Research Background - Objectives - Method Details - Demographic Profile

  • Research Background
  • Method Details
  • Scope
  • Demographic Profile of Respondents

Executive Summary

  • Executive Summary

Overview of Awareness - Usage - Preferences

  • Medication Taken for the Past 6 Months or Longer
  • General Awareness of Drug Delivery Types
  • Overview of Drug Delivery Preferences

Diabetes Type I

  • Drug Delivery Method – Availability & Usage: Diabetes Type I
  • Frequency of Usage of Drug Delivery Method: Diabetes Type I
  • Drug Delivery Method – Satisfaction with Method Used: Diabetes Type I
  • Injection Delivery Device – Diabetes Type I
  • Drug Delivery Method – Willingness to Use: Diabetes Type I
  • Reasons for Willingness to Use Drug Delivery Methods: Diabetes Type I
  • Barriers for Usage of Drug Delivery Methods – Diabetes Type I
  • Reasons for Preference of Drug Delivery Methods – Diabetes Type I

Diabetes Type II

  • Drug Delivery Method – Availability & Usage: Diabetes Type II
  • Frequency of Usage of Drug Delivery Method: Diabetes Type II
  • Drug Delivery Method – Satisfaction with Method Used: Diabetes Type II
  • Injection Delivery Device – Diabetes Type II
  • Drug Delivery Method – Willingness to Use: Diabetes Type II
  • Reasons for Willingness to Use Drug Delivery Methods: Diabetes Type II
  • Barriers for Usage of Drug Delivery Methods – Diabetes Type II
  • Reasons for Preference of Drug Delivery Methods – Diabetes Type II

General Criteria and Perceptions that Influence Drug Delivery Type Preference

  • Factors for Selecting Drug Delivery Type among Diabetes Type I Patients
  • Factors for Selecting Drug Delivery Type among Diabetes Type II Patients
  • Key Source of Discomfort for Drug Delivery Methods Patients are Unwilling to Use Due to High Discomfort
  • Perceived Association of Delivery Types with Various Attributes
  • Person Administering Drug Among Diabetes Type I Patients
  • Person Administering Drug Among Diabetes Type II Patients
  • Drug Regimen – Desirability: Diabetes Type I
  • Drug Regimen – Desirability: Diabetes Type II
  • Device Driven Drug Delivery Method Among Diabetes Type I Patients – Factors
  • Device Driven Drug Delivery Method Among Diabetes Type II Patients – Factors
  • Willingness to Try New Drug Delivery Method Based on Cost and Tolerance for Side Effects
  • Willingness to Try New Drug Delivery Method Based on Price Premium
  • Profile of Diabetes Type I Patients’ Attitudes and Perceptions - An Overview
  • Profile of Diabetes Type II Patients’ Attitudes and Perceptions - An Overview
  • Profile of Patients’ Attitudes and Perceptions

Autoinjector: Usage and Future Adoption

  • Potential Impact of Autoinjector on Injection Delivery Willingness to Use
  • Degree of Willingness to Use Autoinjector in the Future

Profile of Selected Brands: Awareness - Usage - Satisfaction - Desired Improvements

  • Exubera - Awareness
  • Exubera - Usage - Satisfaction - Desired Improvements Among Diabetes Patients
  • Byetta - Awareness
  • Byetta - Usage - Satisfaction - Desired Improvements Among Diabetes Patients

About Frost & Sullivan

  • Frost & Sullivan
Related Research
This study encompasses feedback provided by U.S. diabetes patients on aspects of drug delivery and drug treatment for diabetes, enabling interested stakeholders to gain insight into current and future trends. Data was presented for the general objective point questions as well as analysis by disease subtype where applicable. Patient feedback about awareness, usage, and desired changes was obtained for Exubera and Byetta. For device driven delivery, autoinjector technology usage and willingness for adoption is assessed by patients, as well as other vital feedback on the role the device plays in the overall drug product. The corresponding physician deliverable is titled: 2008 U.S. Diabetes Drug Delivery - Physician Perspective (N7A6).
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number N7C0-01-00-00-00
Is Prebook No